Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00378001 · ClinicalTrials.gov registry record · Phase 3
Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF
A Phase 3 study, sponsored by IBSA Institut Biochimique.
- Completed
- Registry status
- Phase 3
- Development phase
- 152
- Enrollment target
NCT00378001 is a Phase 3 study that has completed, run by IBSA Institut Biochimique. The registered enrollment target is 152 participants.
The verdict
NCT00378001, a Phase 3 study, has completed, sponsored by IBSA Institut Biochimique.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 152 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the clinical efficacy and general tolerability of two different subcutaneous FSH preparations (Fostimon®, IBSA vs Gonal-F®, Serono Inc.) when administered to patients undergoing controlled ovarian stimulation for IVF.
Interventions
- DRUG FSH-IBSA
- DRUG GONAL-F
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00378001
The ClinicalTrials.gov registry entry for NCT00378001 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is IBSA Institut Biochimique, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FSH-IBSA is the first listed.
NCT00378001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00378001 about?
NCT00378001 is a clinical study titled "Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF". The purpose of the study is to evaluate the clinical efficacy and general tolerability of two different subcutaneous FSH preparations (Fostimon®, IBSA vs Gonal-F®, Serono Inc.) when administered to patients undergoing controlled ovarian stimulation for IVF.
What is the current status of trial NCT00378001?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 152 participants. The study started on 2005-03. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00378001?
The interventions under investigation include: FSH-IBSA (DRUG), GONAL-F (DRUG).
Who is sponsoring clinical trial NCT00378001?
This trial is sponsored by IBSA Institut Biochimique, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.